Brief: Delcath Systems Inc Said A Vendor Inadvertently Published Staging Site To Reflect Possibility That U.S. FDA Might Approve Hepzato
04/08/2023 22:35
Aug 4 (Reuters) - Delcath Systems Inc DCTH.O :
* DELCATH SYSTEMS INC - A VENDOR INADVERTENTLY PUBLISHED
STAGING
SITE TO REFLECT POSSIBILITY THAT U.S. FDA MIGHT APPROVE HEPZATO
* DELCATH SYSTEMS INC - TO DATE, CO HAS NOT RECEIVED
DECISION BY
FDA AS TO ITS APPROVAL OF HEPZATO AND TARGET PDUFA DATE REMAINS
AUGUST 14
Source text for Eikon: ID:
Further company coverage: DCTH.O
Recent news on Delcath Systems
See all newsBrief: Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Delcath Systems Q1 revenue beats on Hepzato growth
Brief: Delcath Systems Announces Publication Of Chopin Clinical Trial Results In The Lancet Oncology
Delcath Q4 revenue rises 37%, beats estimates
Brief: Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)